MENU
September 28, 2021: Medtronic announced that it has obtained European CE marking approval for its radial artery access portfolio, which includes the Rist 079 radial access direction catheter and the Rist selective radial access catheter. , Spain, Germany and France.
According to the company, the Rist 079 radial access direction catheter is designed in particular to access the neurovascular formula through the radial artery rather than access through the transfemoral artery. The device has obtained 510(k) approval from the FDA and has been used at limited sites in the United States.
The selective catheter with radial Rist is indicated for the advent of interventional devices in peripheral, coronary and neurovascular vessels. In addition, the selective catheter can be used to facilitate the arrival of diagnostic agents into the neurovascular system. advent of diagnostic agents in the coronary or peripheral arteries.
“With the right airworthiness, this unique device will enable physicians to succeed at dissolution sites while achieving the stability of the right formula,” Alejandro Tomasello, MD, said in Medtronic’s news release. Tomasello, Head of the Interventional Neuroradiology Unit at Vall d’Hebron Hospital in Barcelona, Spain, continued: “The radial artery access portfolio works well in conjunction with Phenom Plus, the Phenom 021 microcatheter for stent deployment or the Phenom 027 microcatheter for deflector deployment, which is a fantastic setup for the Pipeline Vantage embolization device with shield generation treatments. “